Humacyte Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.94

+0.05 (+5.88%)

As of Feb 8, 2:06 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 2 15%

Sell 0 0%

Price Target

Analyst Price Target +1,522.1% upside

Low Target $10.64

Average Target $15.22

High Target $24.41

Current Price $0.94

Current
$0.94

Target
$15.22

$10.64 $15.22 avg $24.41

Scenario Analysis

Bear Case

$10.64

1,034.0%

Low target

Base Case

$15.22

+1,522.1%

Avg target

Bull Case

$24.41

+2,501.5%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$15.73

-94.0% from high

52-Week Low

$9.25

+-89.9% from low

Target vs 52W High

$15.22

-3.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%